Category Archives: Topamax Oral Clefts

Featured Stories
Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Image Source: wisegeek.com

Trial over Ethicon Transvaginal Mesh Begins in California

Pelvic mesh devices have become the subject of safety concerns in recent years amidst reports that they can cause serious, sometimes permanent injuries.

Read More

Janssen Pharmaceuticals to Pay Family $10M Over Child’s Topamax Injuries

janssen-pharmaceuticals-pay-10-million

Janssen Pharmaceuticals Inc. must pay more than $10 million to the family of a child who allegedly suffered Topamax (topiramate) birth defects. The Philadelphia state jury just decided that Janssen did not adequately warn physicians about the epilepsy drug’s birth … Continue reading

Posted in Legal News, Pharmaceuticals, Topamax Oral Clefts |

Study: Topamax Linked to Birth Defects

A new study suggests that taking Topamax during pregnancy could lead to side effects that include birth defects. The study, conducted by researchers at the Royal Melbourne Hospital and University of Melbourne, Australia, looked at Topamax, Depakote (valproate), and Tegretol … Continue reading

Posted in Pharmaceuticals, Topamax Oral Clefts |

Topamax Birth Defect Lawsuits Centralized in Philadelphia

All < "http://www.yourlawyer.com/topics/overview/topamax_birth_defects">Topamax birth defect lawsuits filed in Pennsylvania state courts have been centralized in the Philadelphia Court of Common Pleas. The lawsuits allege that Johnson & Johnson subsidiary, Ortho-McNeil Neurologics, failed to properly research the pregnancy risks associated with … Continue reading

Posted in Pharmaceuticals, Topamax Oral Clefts |

Study Fails to Clarify Topamax Birth Defect Risk

A new study has proven inconclusive on < "http://www.yourlawyer.com/topics/overview/topamax_birth_defects">Topamax birth defects because of the small amount of Topamax patients involved in the fairly large study. The research, said WebMD, reviewed newer antiseizure medications taken by pregnant women during their first … Continue reading

Posted in Topamax Oral Clefts |

Topamax Birth Defect Risk Complicated by Interaction with Birth Control Pills

Women taking < "http://www.yourlawyer.com/topics/overview/topamax_birth_defects">Topamax should be aware that its active ingredient, topiramate, may inhibit the effectiveness of birth control pills. It is especially important that women of child-bearing age be aware of this Topamax side effect, due to its association … Continue reading

Posted in Legal News, Pharmaceuticals, Topamax Oral Clefts |

Topamax Linked to Cleft Lip, Cleft Palate

Another medical group is warning patients about the dangers associated with the anticonvulsant medication < "http://www.yourlawyer.com/topics/overview/topamax-birth-defects-side-effects-clefts-lawsuit">Topamax (generic: topiramate) when used by expectant mothers. Now, the American Academy of Family Physicians (AAFP) is warning family physicians about the increased likelihood of … Continue reading

Posted in Pharmaceuticals, Topamax Oral Clefts |

Be Cautious About Topamax Pregnancy Risk, Headache Group Tells Women

The American Headache Society says women of childbearing age should be careful about using Topamax (topiramate) to treat migraine headaches because of its birth defect risk. The society’s advice followed the Food & Drug Administration’s (FDA) recent warning that women … Continue reading

Posted in Pharmaceuticals, Topamax Oral Clefts |

Topamax Risky for Expectant Moms

We recently wrote that anticonvulsant medication, < "http://www.yourlawyer.com/topics/overview/topamax-birth-defects-side-effects-clefts-lawsuit">Topamax (topiramate), was linked to the development of oral clefts—cleft lip and/or cleft palate—in babies born to women who took the drug during early pregnancy. We also wrote that the U.S. Food & … Continue reading

Posted in Pharmaceuticals, Topamax Oral Clefts |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.